Floatz logo

MEGESTROL ACETATE IMPURITY B

Liver Cancer

National Medical Research Council (NMRC), SingaporeSmall moleculePhase 3Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
65/ 100

Competitive context

112 Active assets in the Liver Cancer cohort.

Asset / SponsorPhaseRating
Bxcl501
Uppsala University Hospital
Phase 4BBB
Inno-206
Shanghai Zhongshan Hospital
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB
SUFENTANYL
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Sorafenib
First Affiliated Hospital Xi'an Jiaotong University
Phase 3BB

View all 50 →

Same molecule, other indications

MEGESTROL ACETATE IMPURITY B is also rated in:

breast carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
HIV wasting syndromeDormant
BB
Indicative ·
68 / 100
View asset →
AnorexiaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →